Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Prevention of Hyperglycemia in Alpelisib-Treated Breast Cancer
NCT04300790Phase 2Completed
- Sponsor
- MEDSIR
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in hyperglycemia, sponsored by MEDSIR. Started Oct 2020; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT04300790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300790.